|
USRE39760E1
(en)
*
|
1988-03-31 |
2007-08-07 |
International Bio-Immune Systems Inc. |
Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
|
|
US6432402B1
(en)
|
1989-05-25 |
2002-08-13 |
Sloan-Kettering Institute For Cancer Research |
Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
|
|
US6805862B1
(en)
|
1989-05-25 |
2004-10-19 |
Sloan-Kattering Institute For Cancer Research |
Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
|
|
US6020145A
(en)
*
|
1989-06-30 |
2000-02-01 |
Bristol-Myers Squibb Company |
Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
|
|
US20030035797A1
(en)
*
|
1992-01-27 |
2003-02-20 |
Sloan-Kettering Institute For Cancer Research |
Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
|
|
US6297041B1
(en)
*
|
1992-03-11 |
2001-10-02 |
Institute Of Virology, Slovak Academy Of Sciences |
MN gene and protein
|
|
ES2199227T5
(es)
*
|
1993-03-29 |
2007-12-01 |
Pfizer Inc. |
Vacunas clostridiales multicomponente que usan adyuvantes de saponina.
|
|
EP0657471B1
(en)
*
|
1993-12-09 |
2001-10-24 |
Centro de Inmunologia Molecular |
Anti ganglioside monoclonal antibodies and their use in the specific active immunotherapy of malignant tumours
|
|
US5977316A
(en)
*
|
1995-01-17 |
1999-11-02 |
The Board Of Trustees Of The University Of Kentucky |
Monoclonal antibody 1A7 and related polypeptides
|
|
US5935821A
(en)
*
|
1995-01-17 |
1999-08-10 |
Board Of Trustees Of The University Of Kentucky |
Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
|
|
US5612030A
(en)
*
|
1995-01-17 |
1997-03-18 |
University Of Kentucky Research Foundation |
Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
|
|
US6949244B1
(en)
*
|
1995-12-20 |
2005-09-27 |
The Board Of Trustees Of The University Of Kentucky |
Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
|
|
US5776746A
(en)
*
|
1996-05-01 |
1998-07-07 |
Genitope Corporation |
Gene amplification methods
|
|
CN1201005C
(zh)
*
|
1996-05-22 |
2005-05-11 |
维文蒂阿生物技术股份有限公司 |
特异性检测癌细胞的抗原结合片段、编码所述片段的dna、以及它们在预防和检测癌症上的用途
|
|
US5853977A
(en)
*
|
1996-07-12 |
1998-12-29 |
Schering Corporation |
Mammalian TNF-α convertases
|
|
US7115722B1
(en)
|
1997-05-22 |
2006-10-03 |
Viventia Biotech, Inc. |
Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
|
|
US20020098190A1
(en)
*
|
1997-06-13 |
2002-07-25 |
Malaya Chatterjee |
Compositions and methods for treating tumors bearing HMFG and CEA antigens
|
|
US20020122807A1
(en)
*
|
1998-07-07 |
2002-09-05 |
Dan Michael D. |
Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
|
|
US20040265318A1
(en)
*
|
1999-01-13 |
2004-12-30 |
Igeneon Krebs-Immunotherapie Forschungs-und Entwicklungs-AG |
Use of antibodies for the vaccination against cancer
|
|
JP4774551B2
(ja)
*
|
1999-01-13 |
2011-09-14 |
アルトロパス ゲーエムベーハー |
抗癌ワクチン接種のための抗体の使用
|
|
FR2793497B1
(fr)
*
|
1999-05-10 |
2003-04-18 |
Centre Nat Rech Scient |
Anticorps monoclonal dirige contre les cellules de carcinome renal humain
|
|
US7737258B2
(en)
*
|
2000-10-18 |
2010-06-15 |
Sloan-Kettering Institute For Cancer Research |
Uses of monoclonal antibody 8H9
|
|
US8501471B2
(en)
|
2000-10-18 |
2013-08-06 |
Sloan-Kettering Institute For Cancer Research |
Uses of monoclonal antibody 8H9
|
|
US8414892B2
(en)
*
|
2000-10-18 |
2013-04-09 |
Sloan-Kettering Institute For Cancer Research |
Uses of monoclonal antibody 8H9
|
|
US7740845B2
(en)
|
2000-10-18 |
2010-06-22 |
Sloan-Kettering Institute For Cancer Research |
Uses of monoclonal antibody 8H9
|
|
US7666424B2
(en)
*
|
2001-10-17 |
2010-02-23 |
Sloan-Kettering Institute For Cancer Research |
Methods of preparing and using single chain anti-tumor antibodies
|
|
US7009040B2
(en)
*
|
2003-01-21 |
2006-03-07 |
Arius Research, Inc. |
Cancerous disease modifying antibodies
|
|
US6833441B2
(en)
*
|
2001-08-01 |
2004-12-21 |
Abmaxis, Inc. |
Compositions and methods for generating chimeric heteromultimers
|
|
WO2003018749A2
(en)
*
|
2001-08-22 |
2003-03-06 |
Shengfeng Li |
Compositions and methods for generating antigen-binding units
|
|
US7175983B2
(en)
*
|
2001-11-02 |
2007-02-13 |
Abmaxis, Inc. |
Adapter-directed display systems
|
|
US7244814B2
(en)
*
|
2002-02-21 |
2007-07-17 |
University Of Medicine & Dentistry Of New Jersey |
Variant Tat proteins and methods for use thereof
|
|
US7053188B2
(en)
*
|
2002-02-22 |
2006-05-30 |
Purdue Research Foundation |
Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
|
|
WO2003074003A2
(en)
*
|
2002-03-01 |
2003-09-12 |
Applied Immune Technologies |
Immunogens for treatment of neoplastic and infectious disease
|
|
MXPA05003049A
(es)
|
2002-09-19 |
2005-11-17 |
Us Gov Health & Human Serv |
Polipeptidos de phlebotomus ariasi, polipeptidos de phlebotomus perniciosus y metodos de uso.
|
|
US7485306B2
(en)
|
2002-10-29 |
2009-02-03 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Lutzomyia longipalpis polypeptides and methods of use
|
|
US7468254B2
(en)
*
|
2003-01-21 |
2008-12-23 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of MCSP
|
|
US7393531B2
(en)
*
|
2003-01-21 |
2008-07-01 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of MCSP
|
|
PL1620456T3
(pl)
*
|
2003-04-18 |
2014-06-30 |
Ose Pharma Int Sa |
Peptydy antygenu związanego z nowotworem HLA-A2 i kompozycje
|
|
RU2007139283A
(ru)
*
|
2005-03-25 |
2009-04-27 |
Гликарт Биотехнологи Аг (Ch) |
АНТИГЕНСВЯЗЫВАЮЩИЕ МОЛЕКУЛЫ, НАПРАВЛЕННЫЕ К MCSP И ОБЛАДАЮЩИЕ ПОВЫШЕННОЙ АФФИННОСТЬЮ СВЯЗЫВАНИЯ Fc-РЕЦЕПТОРА И ЭФФЕКТОРНОЙ ФУНКЦИЕЙ
|
|
ES2423663T3
(es)
|
2005-08-08 |
2013-09-23 |
Oregon Health And Science University |
Inactivación de patógenos con peróxido de hidrógeno para la producción de vacunas
|
|
US20100130425A1
(en)
|
2005-09-09 |
2010-05-27 |
Oregon Health & Science University |
Use of toll-like receptor ligands in treating excitotoxic injury, ischemia and/or hypoxia
|
|
US20070161089A1
(en)
*
|
2005-11-08 |
2007-07-12 |
Genentech, Inc. |
Method of Producing Pan-Specific Antibodies
|
|
EP1994409A2
(en)
|
2006-03-14 |
2008-11-26 |
Oregon Health and Science University |
Methods for producing an immune response to tuberculosis
|
|
CA2678404C
(en)
|
2007-02-28 |
2019-03-19 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Brachyury polypeptides and methods for use
|
|
JP2010523478A
(ja)
*
|
2007-03-22 |
2010-07-15 |
スローン − ケタリング・インスティテュート・フォー・キャンサー・リサーチ |
モノクローナル抗体８ｈ９の使用
|
|
WO2010017209A2
(en)
|
2008-08-04 |
2010-02-11 |
The Government Of The Usa As Represented By The Secretary Of The Department Of Health And Human Services |
Membrane proximal region of hiv gp41 anchored to the lipid layer of a virus-like particle vaccine
|
|
WO2010099472A2
(en)
|
2009-02-27 |
2010-09-02 |
The U.S.A. Of America, As Represented By The Secretary, Department Of Health And Human Services |
Spanx-b polypeptides and their use
|
|
EP2486133B1
(en)
|
2009-10-07 |
2016-06-29 |
UVic Industry Partnerships Inc. |
Vaccines comprising heat-sensitive transgenes
|
|
US9181306B2
(en)
|
2009-10-16 |
2015-11-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine
|
|
EP2502076B1
(en)
|
2009-11-20 |
2018-04-18 |
Oregon Health and Science University |
Methods for detecting a mycobacterium tuberculosis infection
|
|
WO2011112599A2
(en)
|
2010-03-12 |
2011-09-15 |
The United States Of America, As Represented By The Secretary. Department Of Health & Human Services |
Immunogenic pote peptides and methods of use
|
|
CA2842180C
(en)
|
2011-07-18 |
2020-06-23 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions for inhibiting polyomavirus-associated pathology
|
|
WO2013152352A1
(en)
|
2012-04-06 |
2013-10-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic |
Live, attenuated rubella vector to express vaccine antigens
|
|
WO2014043518A1
(en)
|
2012-09-14 |
2014-03-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Brachyury protein, non-poxvirus non-yeast vectors encoding brachyury protein, and their use
|
|
AU2013331328B2
(en)
|
2012-10-19 |
2018-05-31 |
Bavarian Nordic A/S |
Methods and compositions for the treatment of cancer
|
|
EP3079716B1
(en)
|
2013-12-13 |
2019-05-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Multi-epitope tarp peptide vaccine and uses thereof
|
|
WO2015095770A1
(en)
|
2013-12-20 |
2015-06-25 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Immunogenic jc polyomavirus compositions and methods of use
|
|
CN108289940B
(zh)
|
2015-08-03 |
2023-01-13 |
美国卫生和人力服务部 |
Brachyury缺失突变体、编码brachyury缺失突变体的非酵母载体及其用途
|
|
EP3454895B1
(en)
|
2016-05-10 |
2024-03-27 |
Najit Technologies, Inc. |
Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production
|
|
CA3051512A1
(en)
|
2017-01-26 |
2018-08-02 |
Zlip Holding Limited |
Cd47 antigen binding unit and uses thereof
|
|
US11235046B2
(en)
|
2017-11-04 |
2022-02-01 |
Nevada Research & Innovation Corporation |
Immunogenic conjugates and methods of use thereof
|
|
WO2020117590A1
(en)
|
2018-12-04 |
2020-06-11 |
The Rockefeller University |
Hiv vaccine immunogens
|
|
WO2020160156A2
(en)
|
2019-01-30 |
2020-08-06 |
Immutics, Inc. |
Anti-gal3 antibodies and uses thereof
|
|
WO2023288252A1
(en)
|
2021-07-13 |
2023-01-19 |
Truebinding, Inc. |
Methods of preventing protein aggregation
|
|
CN118284624A
(zh)
|
2021-11-19 |
2024-07-02 |
米罗生物有限公司 |
Pd-1抗体及其用途
|
|
AU2023251091A1
(en)
|
2022-04-06 |
2024-10-10 |
Gilead Sciences, Inc. |
Engineered cd200r antibodies and uses thereof
|